ReviewReviews in endocrine & metabolic disorders2010
The economic consequences of diabetes and cardiovascular disease in the United States.
Review in Reviews in endocrine & metabolic disorders, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Racial differences in lifetime healthcare costs associated with obesity-related multimorbidity among the U.S. population aged 40 years or older.medRxiv : the preprint server for health sciences · 2026Article
- Physical Activity of Type 2 Diabetes Mellitus Patients and Non-Diabetes Participants in Yangon, Myanmar: A Case-Control Study Applying the International Physical Activity Questionnaires (IPAQ-S).Diabetes, metabolic syndrome and obesity : targets and therapy · 2021Article
- Time- and frequency-domain measures of heart rate variability predict cardiovascular outcome in patients with type 2 diabetes.Diabetes research and clinical practice · 2018Article
- Dietary Fiber Intake and Type 2 Diabetes Mellitus: An Umbrella Review of Meta-analyses.Journal of chiropractic medicine · 2018Review
- Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease.Journal of managed care & specialty pharmacy · 2018Article
- Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain.The European journal of health economics : HEPAC : health economics in prevention and care · 2016Article
- Racial-ethnic disparities in the association between risk factors and diabetes: The Northern Manhattan Study.Preventive medicine · 2016Article
- Fiber in Diet Is Associated with Improvement of Glycated Hemoglobin and Lipid Profile in Mexican Patients with Type 2 Diabetes.Journal of diabetes research · 2016Article
- Genetics of Type 2 Diabetes in African Americans.Current diabetes reports · 2015Review
- Different angiotensin receptor blockers and incidence of diabetes: a nationwide population-based cohort study.Cardiovascular diabetology · 2014Article
- Diabetes predicts long-term disability in an elderly urban cohort: the Northern Manhattan Study.Annals of epidemiology · 2014Article
- [Metabolic surgery].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2012Review
- The economic burden of inflammatory heart disease in Korea.Korean circulation journal · 2011Article
- Dairy components and risk factors for cardiometabolic syndrome: recent evidence and opportunities for future research.Advances in nutrition (Bethesda, Md.) · 2011Review
- Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM).European journal of clinical pharmacology · 2011Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes-related care and complications constitute a significant proportion of the United States' (US) health care expenditure. Of these complications, cardiovascular disease (CVD) is a major component. Higher morbidity and mortality rates translate to higher costs of care in patients with diabetes compared to those who do not have the disease. Minorities bear a disproportionate burden of diabetes and CVD. We review this disparity and examine potential etiologies for it in Hispanics and African-Americans, the two largest minority groups in the US. We examine strategies in these populations that may improve outcomes in diabetes and CVD, potentially decreasing health care costs.
Indexed as
Identifiers
20191325What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.